Trials / Recruiting
RecruitingNCT07454330
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
A Multicomponent Support Program to Enhance Quality of Life in Chinese Cancer Patients and Survivors (MSP-CCS): Pilot Optimization Trial and Implementation Outcomes
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate different combinations of cancer education sessions, counseling sessions, and peer support meetings developed for Chinese cancer patients and survivors. The researchers will look at whether the combinations are practical and effective, and how they impact participants' quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cancer Education | Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship. Each session will last about 30-60 minutes and will be completed over the phone or by video call. |
| OTHER | Meaning-Centered Counseling | Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS). Each session will last about 45-60 minutes and will be completed over the phone or by video call. |
| OTHER | Peer Support | Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS. The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes. |
| OTHER | Enhanced Standard Care | enhanced standard care ( written cancer information materials in Chinese and referral to counseling) |
Timeline
- Start date
- 2026-02-27
- Primary completion
- 2028-02-01
- Completion
- 2028-02-01
- First posted
- 2026-03-06
- Last updated
- 2026-03-27
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07454330. Inclusion in this directory is not an endorsement.